611 related articles for article (PubMed ID: 34890936)
1. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.
Ma M; Gan L; Jiang Y; Qin N; Li C; Zhang Y; Wang X
Comput Math Methods Med; 2021; 2021():2140465. PubMed ID: 34422088
[TBL] [Abstract][Full Text] [Related]
3. A Clinical-Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases.
Gan L; Ma M; Liu Y; Liu Q; Xin L; Cheng Y; Xu L; Qin N; Jiang Y; Zhang X; Wang X; Ye J
Front Oncol; 2021; 11():786346. PubMed ID: 34993145
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model.
Qi X; Wang W; Pan S; Liu G; Xia L; Duan S; He Y
Acta Radiol; 2024 Feb; 65(2):173-184. PubMed ID: 38017694
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
6. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
8. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
[TBL] [Abstract][Full Text] [Related]
9. Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram.
Zhong J; Zhang C; Hu Y; Zhang J; Liu Y; Si L; Xing Y; Ding D; Geng J; Jiao Q; Zhang H; Yang G; Yao W
Eur Radiol; 2022 Sep; 32(9):6196-6206. PubMed ID: 35364712
[TBL] [Abstract][Full Text] [Related]
10. MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
Choudhery S; Gomez-Cardona D; Favazza CP; Hoskin TL; Haddad TC; Goetz MP; Boughey JC
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S145-S154. PubMed ID: 33160859
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography.
Lee HJ; Nguyen AT; Song MW; Lee JE; Park SB; Jeong WG; Park MH; Lee JS; Park I; Lim HS
Korean J Radiol; 2023 Jun; 24(6):498-511. PubMed ID: 37271204
[TBL] [Abstract][Full Text] [Related]
12. Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.
Nemeth A; Chaudet P; Leporq B; Heudel PE; Barabas F; Tredan O; Treilleux I; Coulon A; Pilleul F; Beuf O
MAGMA; 2021 Dec; 34(6):833-844. PubMed ID: 34255206
[TBL] [Abstract][Full Text] [Related]
13. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
14. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
15. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
18. Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer.
Zeng Q; Xiong F; Liu L; Zhong L; Cai F; Zeng X
Acad Radiol; 2023 Sep; 30 Suppl 2():S38-S49. PubMed ID: 37169624
[TBL] [Abstract][Full Text] [Related]
19. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
Pang J; Wang S; Liao L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
[TBL] [Abstract][Full Text] [Related]
20. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
Shi Z; Huang X; Cheng Z; Xu Z; Lin H; Liu C; Chen X; Liu C; Liang C; Lu C; Cui Y; Han C; Qu J; Shen J; Liu Z
Radiology; 2023 Jul; 308(1):e222830. PubMed ID: 37432083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
